Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 1 | |
Outperform | 3 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in CNY
The 2 analysts offering 12 month price targets for Zhejiang CONBA Pharmaceutical Co., Ltd. have a median target of 6.34, with a high estimate of 7.27 and a low estimate of 5.40. The median estimate represents a 56.93% increase from the last price of 4.04.
High | 80.0% | 7.27 |
Med | 56.9% | 6.34 |
Low | 33.7% | 5.40 |
Dividends
Div growth (TTM) | 33.33% |
---|
More ▼
Earnings history & estimates in CNY
Average growth rate | +65.75% |
More ▼
Revenue history & estimates in CNY
Average growth rate | +19.16% |
More ▼